Rapid onset of neurological symptoms and lithium toxicity on starting meloxicam.
Chen
Leonard
L
Pym
Holly
H
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D018692:Antimanic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077239:Meloxicam; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced*; D013843:Thiazines / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018692:Antimanic Agents; D018020:Lithium Compounds; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam